SUBSCRIBE
SUBSCRIBE
News   FDA

Actelion Ltd.'s (JOBS) Tracleer Gets US Approval for Wider Use

August 10, 2009 | 
1 min read
Bookmark and Share

Reuters -- Europe's biggest biotech company Actelion Ltd said on Monday its Tracleer drug had been granted approval for mildly symptomatic pulmonary arterial hypertension (PAH).
FDA Approvals
MORE ON THIS TOPIC
Axial view of the brain showing a glioblastoma in the left frontal lobe with central necrosis, peripheral infiltration, and early midline shift.
Brain cancer
FDA Greenlights Jazz’s Dordaviprone, First New Treatment for Ultra-Rare Brain Tumor
August 6, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Close-up image of human hand holding wrench. Construction
Earnings
Biopharma CEOs Can’t Dodge Policy Questions as Trump Lobs Wrench into Earnings Season
August 6, 2025
 · 
6 min read
 · 
Annalee Armstrong
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
August 6, 2025
 · 
2 min read
 · 
Heather McKenzie
Start of negative growth trend. Worsening forecast. Cessation of rise inertia, not enough power energy. The risk of recession and sliding into a crisis
Regulatory
Report of Patient Deaths Sends Agios Shares Seesawing
August 5, 2025
 · 
2 min read
 · 
Tristan Manalac